MRelay 2019, an annual fundraising event on the University of Michigan campus to support the American Cancer Society and its commitment to lifesaving research, treatment and care of cancer patients, is April 6!
Exposure to chemotherapy can create hazards for nurses, pharmacists as they deliver lifesaving care to patients, but use of protective devices remains low.
Researchers from the Rogel Cancer Center have found that a genetic mutation seen in about half of all brain tumors produces a response that prevents radiation treatment from working. Altering that response using FDA-approved drugs restores tumors’ sensitivity to radiation therapy, extending survival in mice.
Latest U.S. estimates indicate that since 1989, hundreds of thousands of women's lives have been saved by mammography and improvements in breast cancer treatment. The findings point to progress made in early detection and management of breast cancer.
Researchers from the University of Michigan Rogel Cancer Center will attend the American Association for Cancer Research (AACR) Annual Meeting from Friday, March 29 through Wednesday, April 4, 2019. Many of them plan to participate in poster sessions and oral presentations. Below is a schedule of who is presenting, when, where and on what topic.
The stable structure of circRNA makes it an ideal candidate for biomarkers because it can be detected in blood or urine, making it potentially useful for cancer diagnosis or prognosis.
University of Michigan researchers find infiltrating lymphocytes tie to survival in patients with recurrent larynx cancer; findings suggest super-boosting the immune system before additional treatment.
As genetic testing for breast cancer has become more complex, evaluating a panel of multiple genes, it introduces more uncertainty about the results. But a new study finds that newer, more extensive tests are not causing patients to worry more about their cancer risk.
University of Michigan Rogel Cancer Center member Lori Pierce, M.D., was elected president of the American Society of Clinical Oncology.
The University of Michigan research team retrospectively examined 485 women with autologous breast reconstructions (after mastectomies due to breast cancer) who underwent screening mammography over 15 years. The findings suggest that in addition to surveillance, breast cancer patients who undergo mastectomies and autologous tissue reconstruction may benefit from mammography screening of their flaps.